Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PDE2A | O00408 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | JAK1 | P23458 | 1/20 | 0.41 |
| ▸ | TYK2 | P29597 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29143042 | 0.98 | ALDH1A1 (0.48) | ALDH1A1TSHRCYP3A4HSD17B10TDP1 | |
| Ethylene Glycol SCHEMBL29238126 | 0.92 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP3A4HSD17B10TDP1 | |
| Trifluoromethanesulfonic Acid SCHEMBL6584577 | 0.87 | MEN1 (0.44) | ALDH1A1TSHRCYP3A4HSD17B10TDP1 | |
| SCHEMBL225921 | 0.82 | PDE2A (0.53) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| SCHEMBL29430111 | 0.82 | PDE2A (0.53) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| Water SCHEMBL29058831 | 0.80 | PDE2A (0.52) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| Potassium SCHEMBL30520491 | 0.80 | PDE2A (0.52) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| SCHEMBL28426979 | 0.80 | PDE2A (0.52) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| SCHEMBL27487833 | 0.80 | PDE2A (0.52) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 | |
| Water SCHEMBL30585009 | 0.78 | PDE2A (0.50) | ALDH1A1TSHRHSD17B10PDE2ACHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085486-A | Type II porous liquid containing high-concentration coordination cage and preparation method and application thereof | 南京工业大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117447328-A | Clean production method of oxyfluorfen | 首建科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116655456-A | Method for efficiently purifying and separating 2-chloro-4-trifluoromethyl phenol | 上虞颖泰精细化工有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-5354495-A | Homo- or copolymerizable through ethylenic unsaturation | NIPPON PAINT CO., LTD. (JP) | 1994-10-11 | — | — | US | claimed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| JP-57149269-A | — | — | None | — | — | JP | disclosed |
| US-20260022130-A1 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-12281124-B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2025-04-22 | — | — | US | disclosed |
| CN-119118983-A | Xanthone compound and intermediate thereof, preparation method, pharmaceutical composition and application | 上海药坦药物研究开发有限公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-4474017-A2 | NEW HETEROCYCLIC COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| CN-116554006-B | Method for efficiently recycling oxyfluorfen byproduct 2-chloro-4-trifluoromethylphenol potassium salt and application | 上虞颖泰精细化工有限公司 | 2024-10-18 | — | — | CN | disclosed |
| US-4935413-A | ELASTICITY, ADHESION AND DISPERSIBILITY | NIPPON PAINT CO., LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| EP-0304725-A1 | Process for the preparation of nitro-diphenyl(thio) ethers | BAYER AG (DE) | 1989-03-01 | — | — | EP | disclosed |
| EP-0207621-A2 | Functional polymers and their production | Nippon Paint Co., Ltd. (JP) | 1987-01-07 | — | — | EP | disclosed |
| EP-0177122-A2 | Acrylamide derivatives | Nippon Paint Co., Ltd. (JP) | 1986-04-09 | — | — | EP | disclosed |
| US-4504689-A | Process for the preparation of phenates substituted by halogen groups or of the corresponding phenols | RHONE-POULENC AGROCHIMIE (FR) | 1985-03-12 | — | — | US | disclosed |
| JP-S57149269-A | PHENOXYPYRIDINE COMPOUND | ISHIHARA SANGYO KAISHA LTD | 1982-09-14 | — | — | JP | disclosed |
| US-4013817-A | HALOGENATED AROMATIC HYDROCARBON | BRIDGESTONE TIRE COMPANY LIMITED (JA) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022130-A1 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | LIPC, LIPA, LPL | ALDH1A1 1338/4885TSHR 1083/4885CYP3A4 784/4885 |
| US-12281124-B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | LIPC, LPL, MGLL | ALDH1A1 525/4885TSHR 1624/4885CYP3A4 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.